| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |